|
ENTPD5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.842010E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.232760E-04 |
| Normal-vs-Stage2 |
2.877800E-02 |
| Normal-vs-Stage3 |
3.446000E-02 |
| Normal-vs-Stage4 |
1.203930E-04 |
| Stage1-vs-Stage2 |
4.999400E-01 |
| Stage1-vs-Stage3 |
8.323600E-02 |
| Stage1-vs-Stage4 |
6.840800E-01 |
| Stage2-vs-Stage3 |
6.258400E-01 |
| Stage2-vs-Stage4 |
3.643400E-01 |
| Stage3-vs-Stage4 |
5.786200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.576500E-04 |
| Normal-vs-AfricanAmerican |
6.05630000000135E-05 |
| Normal-vs-Asian |
4.744000E-01 |
| Caucasian-vs-AfricanAmerican |
1.612950E-01 |
| Caucasian-vs-Asian |
4.341400E-01 |
| AfricanAmerican-vs-Asian |
3.437400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.182740E-04 |
| Normal-vs-Female |
1.263500E-03 |
| Male-vs-Female |
1.473770E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.119700E-03 |
| Normal-vs-Extreme_Weight |
1.97428999999527E-05 |
| Normal-vs-Obese |
5.818000E-04 |
| Normal-vs-Extreme_Obese |
3.996000E-04 |
| Normal_Weight-vs-Extreme_Weight |
3.829500E-02 |
| Normal_Weight-vs-Obese |
6.353600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.072200E-01 |
| Extreme_Weight-vs-Obese |
7.904000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.729200E-01 |
| Obese-vs-Extreme_Obese |
6.753400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.640300E-03 |
| Normal-vs-Age(41-60Yrs) |
1.951070E-04 |
| Normal-vs-Age(61-80Yrs) |
2.044700E-04 |
| Normal-vs-Age(81-100Yrs) |
4.939600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.949400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.951200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.958200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.983800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.333400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.235400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.92780000000315E-05 |
| Normal-VS-Type2 PRCC |
2.470200E-02 |
| Normal-VS-KIRP CIMP |
7.44990000023371E-07 |
| Normal-VS-Unclassified PRCC |
1.758430E-04 |
| Type1 PRCC-VS-Type2 PRCC |
5.60170000000193E-05 |
| Type1 PRCC-VS-KIRP CIMP |
8.34809999999964E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
2.431400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.95810004164099E-09 |
| Type2 PRCC-VS-Unclassified PRCC |
1.784270E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
6.04319999999436E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.581700E-03 |
| Normal-vs-N1 |
2.074200E-02 |
| Normal-vs-N2 |
1.079190E-01 |
| N0-vs-N1 |
9.387600E-01 |
| N0-vs-N2 |
5.909800E-01 |
| N1-vs-N2 |
5.172600E-01 |
|
|
